Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 19 - Drugs for skeletal disorders
Patents for A61P 19 - Drugs for skeletal disorders (81,981)
12/2005
12/07/2005EP1601372A2 Clk-peptide and slk-peptide
12/07/2005EP1601351A1 Use of ep2 selective receptor agonists in medical treatment
12/07/2005EP1496917B1 Combination of a beta-2 adrenoceptor agonists and an aminosugars and their use for the treatment immunomodulatory disorders
12/07/2005EP1379528A4 Pyrazolopyrimidines as therapeutic agents
12/07/2005EP1322305B1 Use of r-arylpropionic acids for producing medicaments for treating illnesses with a rheumatic nature
12/07/2005EP1307449B1 1,4-dihydropyridines as bradykinin antagonists
12/07/2005EP1294711B1 1-(pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as modulators of protein kinases
12/07/2005EP1267806B1 Use of cosmetic and pharmaceutical compositions comprising 2-decarboxy-2-phosphinico derivatives of prostaglandins
12/07/2005EP1263978B1 Inflammation-inducible hybrid promoters, vectors containing same and uses thereof
12/07/2005EP1216257B1 Compounds for the treatment of ischemia
12/07/2005EP1216241B1 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment
12/07/2005EP1203583B1 Remedies for arthrosis deformans
12/07/2005EP1178812B1 Methods of making conditioned cell culture medium compositions
12/07/2005EP1171442B1 Xanthine derivatives and analogs as cell signalling inhibitors
12/07/2005EP1147089B1 Phenylphenanthridines with pde-iv inhibiting activity
12/07/2005EP1117412B1 Compositions containing diphosphonic acids
12/07/2005EP0981523B1 Cyclic ether vitamin d3 compounds, 1alpha (oh) 3-epi-vitamin d3 compounds and uses thereof
12/07/2005EP0957917B1 Vitronectin receptor antagonists
12/07/2005EP0944312B1 Compositions and methods for stimulating bone growth
12/07/2005CN1705485A Method of adminstering bisphosphonates
12/07/2005CN1704404A Tricyclic protein kinase inhibitors
12/07/2005CN1230441C Integrin binding peptide derivatives
12/07/2005CN1230433C Cyclic AMP-specific phosphodiesterase inhibitors
12/07/2005CN1230431C Arylmethylamine derivatives for use as tryptase inhibitors
12/07/2005CN1230418C Selective androgen receptor modulators and methods of use thereof
12/07/2005CN1230192C Medicine for treating protrusion of the lumbar intervertebral and preparation method thereof
12/07/2005CN1230181C Bone repairing material
12/07/2005CN1230166C Gyrase inhibitors and uses thereof
12/06/2005US6972321 Monomeric protein of the TGF-β family
12/06/2005US6972296 Antichoelsterol agents; cardiovascular disorders; antihistamines; multiple sclerosis; antihistamines
12/06/2005US6972295 Central nervous system disorders; psychological disorders; antiinflammatory agents; multiple sclerosis
12/06/2005CA2347512C Adenine derivatives
12/06/2005CA2272745C 2-alkyl-19-nor-vitamin d compounds
12/01/2005WO2005113569A1 Novel 3-triazolyl-galactoside inhibitors of galectins
12/01/2005WO2005113568A1 Novel galactoside inhibitors of galectins
12/01/2005WO2005113012A2 Beta adrenergic drug conjugated to bone targeting moiety for modulating bone mass
12/01/2005WO2005112542A2 Cartilage and bone repair composition
12/01/2005WO2005065015A3 Neutralizing antibodies and methods of use thereof
12/01/2005US20050267304 Protein kinase inhibitors; astham; psoriasis; antiinflammatory agents; inflammatory bowel disorders
12/01/2005US20050267205 2,4-dihydroxybenzoic acid derivatives
12/01/2005US20050267196 Reducing tumor necrosis factor; phosphodiesterase inhibitor; anticancer agents; antidepressants; antiinflammatory agents; skin dsorders; antidepressants
12/01/2005US20050267190 Solid-state form of celecoxib having enhanced bioavailability
12/01/2005US20050267189 Celecoxib compositions
12/01/2005US20050267186 Minimal cardivascular and/or sedatory activity; treating pain and allodynia; selective to alpha2B and/or alpha2C adrenergic receptors in preference over alpha2A adrenergic receptors;
12/01/2005US20050267185 1,2,4-triazole derivatives, compositions, process of making and methods of use
12/01/2005US20050267183 Selective estrogen receptor modulators
12/01/2005US20050267165 Il-8 receptor antagonists
12/01/2005US20050267163 Vanilloid receptor ligands and their use in treatments
12/01/2005US20050267129 Dipeptide nitrile cathepsin K inhibitors
12/01/2005US20050267122 Ansamycins having improved pharmacological and biological properties
12/01/2005US20050267114 Triazaspiro[5.5]undecane derivatives and drugs comprising the same as the active ingredient
12/01/2005US20050267113 Autoimmune disease; antiinflammatory agents; antiischemic agents; rheumatic diseases; antiarthritic agents; interleu
12/01/2005US20050267064 Containing unmethylated CpG dinucleotides, and an allergen; desensitization
12/01/2005US20050267062 Endothelial growth factors; antiischemic agents; neovascularization
12/01/2005US20050267057 Redirect a Th2 response to a Th1 response; treating asthma, allergies, infections, cancer immunotherapy; contain unmethylated cytosine-guanine (CpG) dinucleotides
12/01/2005US20050267044 Novel compounds and compositions as cathepsin S inhibitors
12/01/2005US20050267024 Polypeptide, cancer therapy, neovascularization defects, retinopathies, arthritis and psoraisis
12/01/2005US20050266533 Therapeutic fusion protein with enhanced for use in prevention and treatment of cell proliferative, blood and nervous system disorders
12/01/2005US20050266532 Albumin fusion proteins
12/01/2005US20050266485 polynucleotides encoding a hematopoietic cytokine receptor polypeptide, for use in the treatment of cancer; restoring normal blood cell levels in patients suffering from anemia, thrombocytopenia, and neutropenia or receiving chemotherapy for cancer; biodrugs; test detecting a genetic disorder, cancer
12/01/2005US20050266002 Methods for the treatment of cancer using anti-CD40 antibodies
12/01/2005US20050265976 Method of differentiation of morula or inner cell mass cells and method of making lineage-defective embryonic stem cells
12/01/2005CA2826538A1 3-triazolyl-galactoside inhibitors of galectins
12/01/2005CA2567700A1 3-triazolyl-galactoside inhibitors of galectins
12/01/2005CA2567694A1 Novel galactoside inhibitors of galectins
12/01/2005CA2567314A1 Cartilage and bone repair composition
12/01/2005CA2567190A1 Combinations of hyaluronic acid and polyunsaturated fatty acids
12/01/2005CA2566746A1 Beta adrenergic drug conjugated to bone targeting moiety for modulating bone mass
11/2005
11/30/2005EP1600440A1 Indole derivative compounds and drugs containing the compounds as the active ingredient
11/30/2005EP1600166A1 Skeletal muscle protecting agent
11/30/2005EP1600163A1 Use of the neurotoxic component of botulinum toxins for the treatment of spastic muscle
11/30/2005EP1599482A1 Pyrazolo 1,5-a pyrimidine derivatives
11/30/2005EP1599464A2 Novel cyclic urea derivatives, preparation method thereof and pharmaceutical use of same as kinase inhibitors
11/30/2005EP1599207A2 Treatment of excessive osteolyisis with indolinone compounds
11/30/2005EP1599199A2 Methods for treating joint pain or improving sleep using an estrogen agonist/antagonist
11/30/2005EP1599195A1 Use of non-immunosuppressive pipecolic acid derivatives for inducing chondrogenic differentiation
11/30/2005EP1599191A2 Pharmaceutical composition of alendronic acid, salts or esters thereof, and a process for its preparation
11/30/2005EP1432708B1 Preparation and use of 1,5,6,7-tetrahydropyrrolo 3,2-c]pyridine derivatives for treatment of obesity
11/30/2005EP1392337B1 Pharmaceutical formulation consisting of a plant dry extract with a calcium coating
11/30/2005EP1289534B1 Apoptotic entities for use in treatment of t-cell-mediated and inflammatory disorders
11/30/2005EP1224185B1 Thiazole and imidazo[4,5-b]pyridine compounds and their pharmaceutical use
11/30/2005EP1176981B1 Treatment of autoimmune diseases with antagonists which bind to b cell surface markers
11/30/2005EP1144372B1 Sulphohydroxamic acids and sulphohydroxamates and their use as mek inhibitors
11/30/2005EP1109909B1 Grf analogs with increased biological potency
11/30/2005EP1091943B1 Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
11/30/2005EP0963200B9 Compositions for inhibition of angiogenesis comprising thalodomide and a nsaid
11/30/2005CN1703393A Spiro compounds, medicinal compositions containing the same and intermediates of the compounds
11/30/2005CN1703234A The use of low-molecular-weight thrombin inhibitor
11/30/2005CN1703207A Methods for increasing bone formation using inhibitors of glycogen synthase kinase-3 betta
11/30/2005CN1703197A Injectable depot compositions and uses thereof
11/30/2005CN1229373C Piperidinee derivatives as neurokinin1 antagonists
11/30/2005CN1229370C Novel derivatives of flavones, xanthones and coumarins
11/30/2005CN1229353C Method and compositions utilizing quinazolinones
11/30/2005CN1229351C Heterocyclic compounds and methods to treat cardiac failure and other disorders
11/30/2005CN1229343C Chemotactic factor receptor active regulator
11/30/2005CN1229334C Inhibitors of alpha4 mediated cell adhesion
11/30/2005CN1229134C External Chinese patent medicines for curing periarthritis humeroscapularis and myotenositis
11/30/2005CN1229126C Chinese medicine for curing rheumatoid arthritis
11/30/2005CN1229120C Carthamus flower medicated liquor
11/30/2005CN1229118C Bone setting machine
1 ... 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 ... 820